/PRNewswire/ Balance Point Capital Advisors, LLC ("Balance Point"), in conjunction with its affiliated funds, Balance Point Capital Partners IV, L.P. and.
What do Growing Personalized Medicines Demand Mean for Tissue Processor Equipment Market Players? Fact.MR's latest report uncovers details on concealed opportunities in the tissue processor
/PRNewswire/ With a CAGR of 4.8%, the global tissue processor equipment market is expected to grow from US$ 426.30 Million in 2022 to US$ 681 Mn by the end.